List of Studies ( Metabolite:TG 48:6)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003814 | AN006271 | Sulfur Amino Acid Restriction Enhances Exercise Capacity in Mice by Boosting Fat Oxidation in Muscle - extensor digitorum longus (EDL) versus soleus (Sol) on Con and SAAR diet lipidomics | Muscle | Mouse | Princeton University | LC-MS | |
| ST003522 | AN005784 | Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice | Adipose tissue | Mouse | Cancer | Stanford University | LC-MS |
| ST003522 | AN005784 | Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice | Tumor tissue | Mouse | Cancer | Stanford University | LC-MS |
| ST003220 | AN005280 | Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue | Adipose tissue | Mouse | Obesity | University of Utah | LC-MS |
| ST003157 | AN005179 | Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics | Blood | Mouse | Multiple sclerosis | University of Luebeck | LC-MS |
| ST002843 | AN004653 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002842 | AN004651 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002824 | AN004608 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia | Blood | Mouse | Cancer | Rutgers University | LC-MS |
| ST002764 | AN004499 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002729 | AN004426 | Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. | Muscle | Mouse | Diabetes | Medical Institute of Bioregulation, Kyushu University | LC-MS |
| ST002700 | AN004376 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002002 | AN003265 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001950 | AN003174 | Lipidome Alterations Following Mild Traumatic Brain Injury. | Blood | Rat | Traumatic brain injury | Georgia Institute of Technology | LC-MS |
| ST001831 | AN002972 | Nested case–control study of environmental exposure within the ongoing Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) pregnancy cohort (part II) | Blood | Human | University of Michigan | LC-MS | |
| ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | LC-MS | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | LC-MS | |
| ST000987 | AN001613 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | Blood | Human | University of California, Davis | LC-MS | |
| ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | LC-MS | |
| ST000985 | AN001611 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | Blood | Human | University of California, Davis | LC-MS | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | LC-MS | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | LC-MS | |
| ST000915 | AN001488 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000148 | AN000235 | A549 13C-labeled Cell Study | Epithelial cells | Human | Cancer | University of Kentucky | LC-MS |
| ST000114 | AN000192 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000113 | AN000190 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Positive ion mode FTMS) | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000110 | AN000183 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) | B-cells | Human | University of Kentucky | GC-MS/LC-MS | |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS |
